Common use of New Commitments Clause in Contracts

New Commitments. Neither Party will incur new expenses related to this CRADA after expiration, mutual termination, or a notice of a unilateral termination and will, to the extent feasible, cancel all outstanding commitments and contracts by the termination date. Collaborator acknowledges that ICD will have the authority to retain and expend any funds for up to one (1) year subsequent to the expiration or termination date to cover any unpaid costs obligated during the term of the CRADA in undertaking the research and development activities set forth in the Research Plan.

Appears in 19 contracts

Samples: Cooperative Research and Development Agreement, Cooperative Research and Development Agreement, Cooperative Research and Development Agreement (Bavarian Nordic a/S / ADR)

AutoNDA by SimpleDocs

New Commitments. Neither Party will incur new expenses related to this CRADA after expiration, mutual termination, or a notice of a unilateral termination and will, to the extent feasible, cancel all outstanding commitments and contracts by the termination date. Collaborator acknowledges that ICD IC will have the authority to retain and expend any funds for up to one (1) year subsequent to the expiration or termination date to cover any unpaid costs obligated during the term of the CRADA in undertaking the research and development activities set forth in the Research Plan.

Appears in 13 contracts

Samples: Cooperative Research and Development Agreement (Curative Biotechnology Inc), Cooperative Research and Development Agreement (BriaCell Therapeutics Corp.), Cooperative Research and Development Agreement (Scopus BioPharma Inc.)

New Commitments. Neither Party will incur new expenses related to this CRADA after expiration, mutual termination, or a notice of a unilateral termination and will, to the extent feasible, cancel all outstanding commitments and contracts by the termination date. Collaborator acknowledges that ICD will have the authority to retain and expend any funds for up to one (1) year […***…] subsequent to the expiration or termination date to cover any unpaid costs obligated during the term of the CRADA in undertaking the research and development activities set forth in the Research Plan.

Appears in 6 contracts

Samples: Cooperative Research and Development Agreement (Tracon Pharmaceuticals, Inc.), Cooperative Research and Development Agreement (Tracon Pharmaceuticals, Inc.), Cooperative Research and Development Agreement (Tracon Pharmaceuticals Inc)

New Commitments. Neither Party will incur new expenses related to this CRADA after expiration, mutual termination, or a notice of a unilateral termination and will, to the extent feasible, cancel all outstanding commitments and contracts by the termination date. Collaborator acknowledges that ICD CDC will have the authority to retain and expend any funds for up to one (1) year subsequent to the expiration or termination date to cover any unpaid costs obligated during the term of the CRADA in undertaking the research and development activities set forth in the Research Plan.

Appears in 4 contracts

Samples: Cooperative Research and Development Agreement, Cooperative Research and Development Agreement, Cooperative Research and Development Agreement

New Commitments. Neither Party will incur new expenses related to this CRADA after expiration, mutual termination, termination or a notice of a unilateral termination and will, to the extent feasible, cancel all outstanding commitments and contracts by the termination date. Collaborator acknowledges that ICD IC will have the authority to retain and expend any funds for up to one (1) year […***…] years subsequent to the expiration or termination date to cover any unpaid costs obligated during the term of the CRADA in undertaking the research and development activities set forth in the Research Plan.

Appears in 3 contracts

Samples: Cooperative Research and Development Agreement, Cooperative Research and Development Agreement (Tracon Pharmaceuticals, Inc.), Cooperative Research and Development Agreement (Tracon Pharmaceuticals Inc)

New Commitments. Neither Party will incur new expenses related to this CRADA after expiration, mutual termination, termination or a notice of a unilateral termination and will, to the extent feasible, cancel all outstanding commitments and contracts by the termination date. Collaborator acknowledges that ICD IC will have the authority to retain and expend any funds for up to one five (15) year years subsequent to the expiration or termination date to cover any unpaid costs obligated during the term of the CRADA in undertaking the research and development activities set forth in the Research Plan.

Appears in 2 contracts

Samples: Cooperative Research and Development Agreement, Cooperative Research and Development Agreement

New Commitments. Neither Party will incur new expenses related to this CRADA after expiration, mutual termination, or a notice of a unilateral termination and will, to the extent feasible, cancel all outstanding commitments and contracts by the termination date. Collaborator acknowledges that ICD will have the authority to retain and expend any funds for up to one (1) […***…] year subsequent to the expiration or termination date to cover any unpaid costs obligated during the term of the CRADA in undertaking the research and development activities set forth in the Research Plan.. PHS ECT-CRADA CRADA Ref. No.02663 MODEL ADOPTED June 18, 2009

Appears in 2 contracts

Samples: Cooperative Research and Development Agreement (Tracon Pharmaceuticals, Inc.), Cooperative Research and Development Agreement (Tracon Pharmaceuticals Inc)

New Commitments. Neither Party will incur new expenses related to this CRADA after expiration, mutual termination, or a notice of a unilateral termination termination, and each Party will, to the extent feasible, cancel all outstanding commitments and contracts by the termination date. Collaborator acknowledges that ICD IC will have the authority to retain and expend any funds provided by the Collaborator during the term of this CRADA (if any) for up to one (1) year [*] subsequent to the expiration or termination date to cover any unpaid costs obligated during the term of the CRADA in undertaking the research and development activities set forth in the Research Plan.

Appears in 1 contract

Samples: Cooperative Research and Development Agreement (Newlink Genetics Corp)

New Commitments. Neither Party will incur new expenses related to this CRADA after expiration, mutual termination, termination or a notice of a unilateral termination and will, to the extent feasible, cancel all outstanding commitments and contracts by the termination date. Collaborator acknowledges that ICD NCI will have the authority to retain and expend any funds for up to one five (15) year years subsequent to the expiration or termination date to cover any unpaid costs obligated during the term of the CRADA in undertaking the research and development activities set forth in the Research Plan.

Appears in 1 contract

Samples: Cooperative Research and Development Agreement

New Commitments. Neither Party will incur new expenses related to this CRADA after expiration, mutual termination, or a notice of a unilateral termination and will, to the extent feasible, cancel all outstanding commitments and contracts by the termination date. Collaborator acknowledges that ICD IC will have the authority to retain and expend any funds for up to one (1) year subsequent to the expiration or termination date to cover any unpaid costs obligated during the term of the CRADA in undertaking the research and development activities set forth in the Research Plan.. PHS CRADA Agreement Ref. No. 2020-12 MODEL ADOPTED June 18, 2009

Appears in 1 contract

Samples: Cooperative Research and Development Agreement (Virpax Pharmaceuticals, Inc.)

AutoNDA by SimpleDocs

New Commitments. Neither Party will incur new expenses related to this CRADA after expiration, mutual termination, or a notice of a unilateral termination and will, to the extent feasible, cancel all outstanding commitments and contracts by the termination date. Collaborator acknowledges that ICD FDA will have the authority to retain and expend any funds for up to one (1) year subsequent to the expiration or termination date to cover any unpaid costs obligated during the term of the CRADA in undertaking the research and development activities set forth in the Research PlanPIan.

Appears in 1 contract

Samples: Cooperative Research and Development Agreement (BG Medicine, Inc.)

New Commitments. Neither Party will incur new expenses related to this CRADA after expiration, mutual termination, termination or a notice of a unilateral termination and will, to the extent feasible, cancel all outstanding commitments and contracts by the termination date. Collaborator acknowledges that ICD NCI will have the authority to retain and expend any necessary funds for up to one five (15) year years subsequent to the expiration or termination date to cover any unpaid unpaid, undisputed costs obligated during the term of the CRADA in undertaking the research and development activities set forth in the Research PlanPlan in accordance with this CRADA.

Appears in 1 contract

Samples: Cooperative Research and Development Agreement

New Commitments. Neither Party will incur new expenses related to this CRADA after expiration, mutual termination, termination or a notice of a unilateral termination and will, to the extent feasible, cancel all outstanding commitments and contracts by the termination date. Collaborator acknowledges that ICD NCI will have the authority to retain and expend any necessary funds for up to one five (15) year years subsequent to the expiration or termination date to cover any unpaid unpaid, undisputed costs obligated during the term Term of the CRADA in undertaking the research and development activities set forth in the Research PlanPlan in accordance with this CRADA.

Appears in 1 contract

Samples: Cooperative Research and Development Agreement

New Commitments. Neither Party will incur new expenses related to this CRADA after expiration, or mutual termination, or a notice of a unilateral termination and will, to the extent feasible, cancel all outstanding commitments and contracts by the termination date. Collaborator acknowledges that ICD IC will have the authority to retain and expend any funds previously paid by Collaborator for up to one two and one-half (12.5) year years subsequent to the expiration or termination date to cover any unpaid costs obligated during the term of the CRADA in undertaking the research and development activities set forth in the Research Plan.

Appears in 1 contract

Samples: Cooperative Research and Development Agreement (Exelixis, Inc.)

New Commitments. Neither Party will incur new expenses related to this CRADA after expiration, mutual termination, or a notice of a unilateral termination and will, to the extent feasible, cancel all outstanding commitments and contracts by the termination date. Collaborator acknowledges that ICD will have the authority to retain and expend any funds for up to one (1) year [*] subsequent to the expiration or termination date to cover any unpaid costs obligated during the term of the CRADA in undertaking the research and development activities set forth in the Research Plan.

Appears in 1 contract

Samples: Cooperative Research and Development Agreement (Introgen Therapeutics Inc)

New Commitments. Neither Party will incur new expenses related to this CRADA after expiration, mutual termination, or a notice of a unilateral termination and will, to the extent feasible, cancel all outstanding commitments and contracts by the termination date. Collaborator acknowledges that ICD will have the authority to retain and expend any funds for up to one (1) year subsequent to the expiration or termination date to cover any unpaid costs obligated during the term of the CRADA in undertaking the research and development activities set forth in the Research Plan.. PHS ICT-CRADA Case Ref. No. _______ MODEL ADOPTED June 18, 2009

Appears in 1 contract

Samples: Cooperative Research and Development Agreement (Genesis Biopharma, Inc)

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!